DexCom, Inc. - Common Stock (NQ:DXCM)

86.90 +1.54 (+1.80%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

50 51 Next >

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

April 10, 2025

From DexCom, Inc.

Via Business Wire

What 6 Analyst Ratings Have To Say About DexCom ↗

April 10, 2025

Via Benzinga

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

April 08, 2025

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry ↗

April 04, 2025

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...

Via Benzinga

Topics Government World Trade

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

April 03, 2025

From DexCom, Inc.

Via Business Wire

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

April 03, 2025

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

Via StockStory

Topics Artificial Intelligence

10 Worst Performing Large-Caps Last 12 Months ↗

March 27, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

The Future of Healthcare: 10 Predictions For The Next Decade

March 27, 2025

The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...

Via MarketMinute

Topics Artificial Intelligence

Dexcom Appoints Jon Coleman as Chief Commercial Officer

March 25, 2025

From DexCom, Inc.

Via Business Wire

Tuesday's session: top gainers and losers in the S&P500 index ↗

March 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. ↗

March 24, 2025

Based on a technical and fundamental analysis of NASDAQ:DXCM we ask: Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

DexCom (DXCM): 3 Reasons We Love This Stock

March 24, 2025

Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next...

Via StockStory

Topics Stocks

Is DexCom Gaining or Losing Market Support? ↗

March 21, 2025

Via Benzinga

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

March 21, 2025

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Exploring the top movers within the S&P500 index during today's session. ↗

March 20, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Top S&P500 movers in Thursday's session ↗

March 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next ↗

March 19, 2025

Via The Motley Fool

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

March 19, 2025

From DexCom, Inc.

Via Business Wire

10 Worst Performing Large-Caps Last 12 Months ↗

March 13, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

March 11, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...

Via StockStory

Topics Artificial Intelligence

Which S&P500 stocks are moving on Monday? ↗

March 10, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried ↗

March 10, 2025

The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.

Via Investor's Business Daily

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

March 10, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Dexcom Appoints Renée Galá to Board of Directors

March 10, 2025

From DexCom, Inc.

Via Business Wire

DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

March 03, 2025

Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

3 Growth Stocks to Buy and Hold Forever ↗

March 01, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Dexcom Announces Upcoming Conference Presentation

February 27, 2025

From DexCom, Inc.

Via Business Wire

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

February 27, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...

Via StockStory

Topics Artificial Intelligence

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

February 26, 2025

Via The Motley Fool

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.